Human Vaccines Market Worldwide Is Projected to Grow by US$ 12,806.4 Million, Driven by a Compounded Growth of 7.1%: GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur
In January 2018, India-based pharmaceutical company, Bharat Biotech, in collaboration with Typhoid Vaccine Acceleration Consortium (TVAC), received pre-qualification for its typhoid conjugate vaccine—Typbar TCV—from the World Health Organisation. Moreover, companies are focusing on geographic expansion to generate more revenue. For instance, in July 2020, Pfizer, Inc. introduced its Meningitis B jab TRUMENBA in the U.K. for adults aged 18-25 years.
View full press release